Abbott Laboratories says FDA independent panel votes to approve heart device

February 14, 2024

Abbott Laboratories
ABT,
-1.06%
said that a Food and Drug Administration panel voted in favor of the safety profile of its heart device TriClip.

The medical device company on Tuesday said that the Circulatory System Devices Panel of the Medical Devices Advisory Committee also confirmed the effectiveness and risk/benefit profile of the device to treat people with tricuspid regurgitation.

Tricuspid regurgitation is a type of heart valve disease that occurs when the tricuspid valve doesn’t close tight enough.

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…